Piramal shares rise on Glaxo, Sanofi buy reports
Piramal shares rise on Glaxo, Sanofi buy reports
Mumbai: On reports that GlaxoSmithKline Plc and Sanofi Aventis SA had emerged as bidders for the Indian pharmaceutical firm Piramal Healthcare Ltd, its shares surged up by almost a fourth.
However, Piramal said reports of a potential sale of the company were “unfounded."
The shares opened up 3.4% and rapidly rode up to Rs242, up 24.5%.
At 10:04am, Piramal shares were trading at Rs232, up 19.3%.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!